Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yisaipu in Axial Spondyloarthritis with Peripheral Enthesitis
NCT02960035Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2014
- Primary completion
- Sep 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etanercept in axial spondyloarthritis (axSpA) (3 arms), sponsored by Sun Yat-sen University. Primary endpoint: Madrid Sonographic Enthesis Index at 24 weeks. Started Apr 2014; status: completed.
02
Drugs
etanercept
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT02960035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02960035.